-
WW International Shares Jump On BCBS Michigan's Revised Authorization For Wegovy, Other Weight Loss Drugs
Friday, September 22, 2023 - 4:25pm | 565Read More...Shares of WW International Inc (NASDAQ:WW) spiked as much as 15% on Friday after Blue Cross Blue Shield of Michigan and Blue Care Network announced changes to the prior authorization coverage criteria for certain brand-name weight loss medications. What Happened: Starting Oct. 1, Blue Cross Blue...
-
VIVUS Shares Hit Hard After Earnings
Wednesday, November 7, 2012 - 9:30am | 313Read More...Obesity drug manufacturer VIVUS (NASDAQ: VVUS) slumped 22 percent in early trade Tuesday, as the company reported a net loss of $40.40 million or $0.40 per share in the third quarter. Analysts and investors had anticipated losses of $0.32 for the recently approved Qsymia makers. VIVUS announced...
-
After-Hours: Vivus Shares Down Following Earnings Update
Tuesday, August 7, 2012 - 4:44pm | 213Read More...Shares of biotechnology firm VIVUS (NASDAQ: VVUS) traded lower by almost three percent in Tuesday's after-hours session after the company reported a second-quarter loss of $24 million, or 24 cents a share, compared with a year-earlier loss of $16.2 million, or 20 cents per share. The increase in...
-
Wednesday Market Movers
Wednesday, July 18, 2012 - 12:31pm | 442Read More...VIVUS Inc. (NASDAQ: VVUS): VIVUS Inc., a biopharmaceutical company, announced on Tuesday that the FDA approved its new weight loss drug Qsymia. There is a large market for weight loss drugs because of the pervasiveness of obesity in the United States. In late June, the FDA approved another weight...
